Amy Mahery

Amy Mahery serves as Chief Marketing Officer at Moderna since February 2025 and holds the position of Director on the Board of CNS Pharmaceuticals, Inc. since January 2024, where responsibilities include chairing the Compensation Committee and participating in the Audit Committee. As an advisor at NeuroX1 Inc. from January 2023, Amy contributes to strategic partnerships and fundraising in the AI-driven neurodegenerative disease space. Previously, as Chief Commercial Officer at Roivant Sciences from August 2022 to December 2024, Amy transformed the company into a prominent biotech firm by developing and executing commercial strategies. Amy’s extensive experience at EMD Serono, spanning nearly two decades, includes roles such as Senior Vice President of Global Business Franchise in Neurology & Immunology and Vice President of Global Market Access and Pricing. Educational credentials feature a B.S. in Neuroscience from Trinity College-Hartford and executive education from INSEAD and Stanford University, complemented by recent board training certification.